InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Explore the complete record of transactions filed by Kutan Serkan, Chief Technology Officer. Director active across 1 companies, notably American Well Corp. In total, 9 reports have been published. Total volume traded: €363k. The latest transaction was filed on 1 June 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations9 total
€53,29315,902 shares@ €3.35140.042% mcap4.0% of flow
Class A Common Stock
SEC:0001209191-22-033777:0·
€64,98119,575 shares@ €3.31960.051% mcap4.9% of flow
Class A Common Stock
SEC:0001209191-22-025058:0·
€62,84917,893 shares@ €3.51250.050% mcap4.7% of flow
Class A Common Stock
SEC:0001209191-22-015785:0·
€10,5111,800 shares@ €5.83960.0083% mcap1.8% of flow
Class A Common Stock
SEC:0001209191-21-068863·
€10,5111,800 shares@ €5.83960.0083% mcap0.8% of flow
Class A Common Stock
SEC:0001209191-21-068863:0·
€80,60314,300 shares@ €5.63660.064% mcap14.1% of flow
Class A Common Stock
SEC:0001209191-21-067907·
€80,60314,300 shares@ €5.63660.064% mcap6.1% of flow
Class A Common Stock
SEC:0001209191-21-067907:0·
€481,36954,956 shares@ €8.75920.38% mcap84.1% of flow
Class A Common Stock
SEC:0001209191-21-051680·
€481,36954,956 shares@ €8.75920.38% mcap36.3% of flow
Class A Common Stock
SEC:0001209191-21-051680:0·
9 of 9 declarations
About Kutan Serkan
Serkan Kutan is the Chief Technology Officer at American Well Corp. He is responsible for the company's technology strategy and innovation. With a strong background in developing technological solutions, he plays a key role in enhancing the telemedicine services offered by American Well. His expertise contributes to the company's digital transformation.
